Sukhwinder Thandi

Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial

Jonathan Ross, Clare Brittain, Michelle Cole et al. · The Lancet · 2019 · 118 citations · Full text

Acceptability of and treatment preferences for recurrent bacterial vaginosis—Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trial

Jocelyn Anstey Watkins, Jonathan Ross, Sukhwinder Thandi et al. · PLoS ONE · 2019 · 25 citations · Full text

Gentamicin, azithromycin and ceftriaxone in the treatment of gonorrhoea: the relationship between antibiotic MIC and clinical outcome

Michelle Cole, Wei Tan, Helen Fifer et al. · Journal of Antimicrobial Chemotherapy · 2019 · 19 citations · Full text

Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis

Lindsay Armstrong-Buisseret, Clare Brittain, Miruna David et al. · Trials · 2019 · 12 citations · Full text

Gentamicin as an alternative to ceftriaxone in the treatment of gonorrhoea: the G-TOG non-inferiority RCT

Jonathan Ross, J. W. Harding, Lelia Duley et al. · Health Technology Assessment · 2019 · 10 citations · Full text